SCPX — Scorpius Holdings Share News
0.000.00%
Last trade - 00:00- $0.01m
- $11.13m
- $6.24m
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company
Brief: Scorpius Holdings Says 3I, Lp Reported Passive Stake Of 9.9% In Co
Brief: Scorpius Prices Underwritten Public Offering Of 12.5 MLN Shares
Brief: NYSE American To Commence Delisting Proceedings Against Scorpius Holdings, Inc. (Scpx)
Brief: Scorpius Holdings Announces Closing Of Public Offering
Brief: Scorpius Holdings Announces Pricing Of Public Offering
Brief: Scorpius Holdings Inc Announces Firm Commitment Public Offering Of 58.8 Mln Shares
Brief: Scorpius Holdings Got Notice From NYSE Stating That Co Not In Compliance With Continued Listing Standards
Brief: Heat Biologics Inc Says On Jan 31, Co, Elusys Therapeutics Irrevocably Waived Until Feb. 28, 2022 Their Right To Terminate Deal, Plan Of Merger And Reorganization
Brief: Heat Biologics Announces Planned Transfer To The NYSE American
U.S. STOCKS ON THE MOVE-Groupon, Moderna, Knightscope
U.S. STOCKS ON THE MOVE-Netflix, Boeing, Ocuphire Pharma
Heat Biologics rises as future arm Elusys finalizes $80 mln U.S. govt contract
Brief: Elusys Therapeutics Finalizes HHS Contract To Deliver Anthim
Brief: Heat Biologics Announces New PTX-35 Preclinical Data In Organ Transplantation And Provides Update On HS-110
Brief: Heat Biologics Announces Planned Acquisition Of Elusys Therapeutics